• Explore /
  • Poster
  • / Phase I/III trial of atezolizumab with carboplatin and etoposide in ES-SCLC in first-line setting (IMpower133).

Phase I/III trial of atezolizumab with carboplatin and etoposide in ES-SCLC in first-line setting (IMpower133).

Abstract Poster

Authors

Leora Horn

Leora Horn

Vanderbilt University Medical Center, Nashville, TN

Leora Horn , Aaron Scott Mansfield , Martin Reck , Tony Mok , Alexander I. Spira , Xiongwen Tang , Sivuonthanh Lam , Fairooz F. Kabbinavar , Ariel Lopez-Chavez , Alan Sandler , Stephen V. Liu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

Track

Lung Cancer

Sub Track

Small Cell Lung Cancer

Clinical Trial Registration Number

NCT02763579

Citation

J Clin Oncol 35, 2017 (suppl; abstr TPS8584)

DOI

10.1200/JCO.2017.35.15_suppl.TPS8584

Abstract #

TPS8584

Poster Bd #

315b

Abstract Disclosures

Similar Posters

First Author: Vassiliki Papadimitrakopoulou

First Author: Yun Fan

First Author: Jacob Sands

First Author: Rui-Hua Xu